|
|
|
|
|
| September 16,
2010 | ISSUE NUMBER 166 VOL 8 |
Strategy
Recasting Big Pharma’s R&D Role: Wellcome Trust or
Wal-Mart?
Should Big Pharma continue to invest in costly in-house research or focus on the service platform skills that can achieve higher margins?
Layoffs
What’s Behind the Genzyme Job Cuts?
The biotech company stands to shed 1,000 jobs out of its 12,800-person workforce. Anything to do with the Sanofi-Aventis takeover bid?
Sales & Marketing
Big Pharma Reps Compete with Local Players in Emerging Markets
Pharma may be fast becoming a global marketplace, but emerging market physicians still prefer the local touch when it comes to reps.
Global
Biosimilars: A SWOT Analysis
Anjan Selz of Finox AG (Switzerland) looks at the strengths, weaknesses, opportunities, and threats of the biosimilars market.
|
|
 // GSK appointed Goldman Sachs M&A exec Simon Dingemansas CFO-designate in January, and announced he takes over the position fully in March 2011. // Rexahn Pharmaceuticals (Rockville, Md.) announced the appointment of Peter Brandt and Richard Kivel to the company’s board of directors. // AVEO Pharmaceuticals (Cambridge, Mass.) appointed Michael Bailey to the newly created role of Chief Commercial Officer, and Donna Radzik, PhD, to the newly created role of Vice President, Technical Operations. // |
|
|
|
Release Higher Performance Through Business Analytics
Wednesday, Sept. 22, 11 A.M. Eastern; 8 A.M. Pacific
Register Free at http://pharmexec.com/analytics
3-D Segmentation: Managing your Brand’s Three Most Important Influencers
Thursday, Oct. 7, at 12 P.M. Eastern; 9 A.M. Pacific
Register Free at http://pharmexec.com/geo |
| |
Advertisement:
ICAP Ocean Tomo Pharma Small Molecule Live Auction
March 31, 2011 – New York City
Participate in the world’s first Pharma Small Molecule Live Auction. Designed to optimize small molecule transactions, ICAP Ocean Tomo auctions streamline processes and documentation for the listing, due diligence, and sale of drug compounds.
To learn more, visit
 www.icapoceantomo.com/pharma
|
|
| |
|
| |
|
|
|
 |
|
 |
|
 |
| What are your main concerns about outsourcing to the emerging markets? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
